Halo Healthcare, Inc

Halo Healthcare, Inc. is a 2012 restructured and recapitalized Southern California growth company, founded as NeoMatrix LLC. The Company’s mission is to provide women with early, affordable, noninvasive, breast cancer risk assessment and detection tests. An annual FDA cleared HALO® Breast Test provides women and physicians scaled risk data for developing breast cancer, enabling proactive personalized breast cancer prevention measures. The HALO Breast Test is particularly valuable for women with a family history, dense breasts, and those on hormones. HaloHC will operate clinical laboratories for increased revenues, improved affordability, and accelerated adoption. The Company has a technology platform focused on protein-based biomolecular diagnostic products for sustainable growth. The AURA Breast Test is in clinical development and will revolutionize the diagnosis of breast cancer using proprietary biomarkers licensed by the Company.

The company, founded in 2006, operates in the Health Care industry. Currently, there is no available information on its headquarters, last investment, or the investors involved in the last investment round.